EP Patent

EP1270034A2 — Inhaler device

Assigned to Plastiape SpA · Expires 2003-01-02 · 23y expired

What this patent protects

An inhaler device comprises an inhaler body defining a recess for a capsule holding herein, a substance to be inhaled, and a nosepiece communicating with the capsule, and a perforating element coupled to the inhaler body and provided for perforating the capsule for allowing an ou…

USPTO Abstract

An inhaler device comprises an inhaler body defining a recess for a capsule holding herein, a substance to be inhaled, and a nosepiece communicating with the capsule, and a perforating element coupled to the inhaler body and provided for perforating the capsule for allowing an outside air flow to be mixed with the capsule contents and inhaled through the nosepiece.

Drugs covered by this patent

Patent Metadata

Patent number
EP1270034A2
Jurisdiction
EP
Classification
—
Expires
2003-01-02
Drug substance claim
No
Drug product claim
No
Assignee
Plastiape SpA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.